A rapid breath test for invasive aspergillosis

Ended Project Grant Awarded Last action

Award ID
R44AI141264
Recipient
Awarding agency
Obligated
$5,289,929

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $4,289,929.31 Federal
  • $1,000,000.00 Non-federal
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$10,071 $0
Amendment $0 $0
Amendment $1,000,000 $0
Amendment A rapid breath test for invasive aspergillosis - invasive aspergillosis (IA) is a leading cause of morbidity and death in immunocompromised patients, with… $1,000,000 $1,000,000
Amendment $1,000,000 $0
Amendment -$4 $0
Amendment $4 $0
Amendment $0 $0
Amendment $1,000,000 $0
Amendment $0 $0
Original award $300,000 $0
Show all 11

Quick answers

Who received award R44AI141264?

R44AI141264 was awarded to Volatylix, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2018.

How much is award R44AI141264 worth?

$5,289,929 has been obligated on R44AI141264: $4,289,929 in federal funding and $1,000,000 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award